sema + cagrilintide blend Cagri/Sema - Cagri 5mg - 5mg Lypholized Powder Total 10mg Cagrilintide & GLP-1 S |

IV administration has been used in rodent research but is rarely used by human self-experimenters due to sterility and safety requirements

Bloodwork may be recommended to confirm

It may also protect against acute kidney injury caused by sepsis in animal models (Li 2014)

Common symptoms include: Anemia Intestinal issues and weight loss Fatigue, weakness, or lightheadedness Memory loss or confusion Depression or dementia Rapid heartbeat and respiration Mouth or tongue soreness or bleeding Excessive bruising Vitamin B12 injections are the most effective administration method, bypassing absorption issues in the gastrointestinal tract